Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Blood|October 15, 2011
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up studyWing-Yan Au, Cyrus R Kumana, Harold K K Lee, et al.Stroke|July 1, 1992
Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trialY L Yu, C R Kumana, I J Lauder, et al.British Journal of Clinical Pharmacology|November 18, 2003
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporinCyrus R Kumana, Matthew K L Tong, Chun-Sang Li, et al.The Journal of Endocrinology|May 7, 2004
Increased adrenomedullin expression in lungs in endotoxaemiaB M Y Cheung, I S S Hwang, C Y Y Li, et al.Journal of Primary Care & Community Health|August 23, 2022
Understanding Questions and Concerns Regarding COVID-19 and the COVID-19 Vaccine Among Populations Presenting at a COVID-19 Vaccine Clinic Hub: A Qualitative StudyHari N Krishnakumar, Gretchel A Gealogo, Taylor Holland, et al.Blood Advances|July 16, 2021
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide studyHarinder Gill, Yammy Yung, Hiu-Tung Chu, et al.Cancer|March 27, 2018
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective studyHarinder Gill, Rita Yim, Harold K K Lee, et al.BMC Cancer|February 11, 2023
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021Harinder Gill, Radha Raghupathy, Carmen Y Y Lee, et al.Burns : Journal of the International Society for Burn Injuries|May 6, 2025
Evaluating inter-and intra-rater reliability in the bronchoscopic grading of burn inhalation injury: The iBRONCH-BII studyEleana T Kumana, Walton N Charles, Helena Milton-Jones, et al.Cancer|May 16, 2019
Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective studyHarinder Gill, Cyrus R Kumana, Rita Yim, et al.Pageof 9